Results for 'diagnostic'
Empowering Oncologists for Patient-Centered Progress
diagnostic, digital, molecular residual disease, MRD
Pulse of the Oncologist survey reveals trends in cancer diagnostics, digital solutions, care barriers, and the innovations transforming oncology today.
Apr 14th • 22 mins listen
Enhancing Cancer Treatment Decisions with Ultrasensitive MRD Testing
Quest Diagnostics, Jesus Izaguirre Carbonell, Thoman Slavin, MRD testing, minimal residual testing, precision tool, biomarker, ctDNA, circulating tumor DNA
Dr. Thomas Slavin breaks down how ultrasensitive MRD testing supports better cancer treatment decisions and enables earlier, more personalized interventions.
Jul 7th • 19 mins listen
Why Genetic Testing Should Be Standard in Prostate Cancer
diagnostic, genetic counselor, genetic testing, prostate cancer, urologic oncology, digital
Hear why universal genetic testing matters in prostate cancer — plus, how it can improve treatment, equity, and outcomes for patients everywhere.
May 18th • 19 mins listen
Tumor-Agnostic Therapies and the Future of HER2 in Oncology
diagnostic, precision oncology, tumor agnostic, breast cancer, gastric cancer, biomarker
What tumor-agnostic approvals mean for HER2, NGS, and precision oncology — and how they’re changing treatment across cancer types.
Jun 8th • 20 mins listen
Rethinking How We Track and Treat Cancer
diagnostic, genomics, breast cancer, antibody drug conjugate, ADC, breast cancer, lung cancer, biomarker
HER2, HER3, and MRD: Drs. Previs and Green break down ASCO highlights and what they mean for the future of cancer diagnostics.
Jul 13th • 19 mins listen
Why Comprehensive Testing Matters - Ken Schlosser’s Lung Cancer Story
diagnostic, biomarker, lung cancer, advocacy, precision
Biomarker testing helped Ken Schlosser live with stage IV lung cancer for over 6 years. Here's how it shaped his care plan from the start.
Jul 31st • 23 mins listen
Redefining Ovarian Cancer Care with Biomarkers
diagnostic, ovarian cancer, biomarker, tumor biology
Exploring ovarian cancer, biomarkers HRD & RB1, and how Labcorp innovations are advancing precision oncology.
Sep 7th • 14 mins listen
Empowering Breast Cancer Patients: Biomarker Breakthroughs & Self-Advocacy
diagnostic, breast cancer, digital, biomarker, genetic testing, advocacy
Suzanne Garner’s journey shows how education, advocacy, and technology are reshaping breast cancer patient care and clinical trial access.
Oct 19th • 26 mins listen
ctDNA Breakthroughs in Mesothelioma Care
diagnostic, immunotherapy, imaging
Exploring immunotherapy and ctDNA innovation in mesothelioma, where molecular monitoring may redefine early cancer detection and treatment.
Nov 3rd • 15 mins listen
FFPE: The Workhorse Behind NGS Testing
biomarker, sequencing, diagnostics, translational research, precision
Exploring FFPE’s impact on precision oncology, NGS innovation, and the future of tissue stewardship in cancer care with leading Labcorp experts.
Jan 28th • 33 mins listen
Navigating the Future of CDXs in Oncology
precision oncology, companion diagnostics, CDx, biomarker, precision medicine
CDX expert Dawn McHugh joins Dr. Rebecca Previs to unpack the role of companion diagnostics in precision oncology and the future of cancer care.
Feb 18th • 26 mins listen
Diagnostic MSL - More Similar Than Different E199 • Apr 2, 2024 • 23 mins
diagnostic MSL, therapeutic MSL, medical affairs, career satisfaction, key performance metrics
In this episode, Keith Fairall joins Tom Caravela to delve into the unique and evolving role of the diagnostic MSL. They explore the distinctions between diagnostic and therapeutic MSL positions, emphasizing the excitement and value diagnostic MSLs bring to the field. Keith and Tom discuss the …
Apr 2nd • 23 mins listen
Dx to Rx – Transitioning from Diagnostics to Pharma
digital marketing, content strategy, search engine optimization, keyword research, online advertising
In this episode, Namratha Sastry shares her journey into the Medical Science Liaison (MSL) role, beginning with her first experience at Biodesics. She delves into the importance of networking in career transitions, particularly moving from diagnostics to pharma, and discusses the regulatory dif…
Dec 20th • 36 mins listen